US HB6888 | 2021-2022 | 117th Congress
Status
Spectrum: Bipartisan Bill
Status: Introduced on March 1 2022 - 25% progression, died in committee
Action: 2022-03-02 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on March 1 2022 - 25% progression, died in committee
Action: 2022-03-02 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Summary
To amend the Federal Food, Drug, and Cosmetic Act to improve the treatment of rare diseases and conditions, and for other purposes.
Title
Helping Experts Accelerate Rare Treatments Act of 2022
Sponsors
| Rep. Paul Tonko [D-NY] | Rep. David McKinley [R-WV] |
History
| Date | Chamber | Action |
|---|---|---|
| 2022-03-02 | House | Referred to the Subcommittee on Health. |
| 2022-03-01 | House | Referred to the House Committee on Energy and Commerce. |
| 2022-03-01 | House | Introduced in House |
Same As/Similar To
HB7667 (Related) 2022-06-09 - Received in the Senate.
Subjects
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/117th-congress/house-bill/6888/all-info |
| Text | https://www.congress.gov/117/bills/hr6888/BILLS-117hr6888ih.pdf |
